MA03.05 BRAF Mutations Are Associated with Increased Benefit from PD1/PDL1 Blockade Compared with Other Oncogenic Drivers in Non-Small Cell Lung Cancer
Resource Type
Abstract
Authors
Negrao, M. ; Skoulidis, F. ; Montesion, M. ; Schulze, K. ; Bara, I. ; Shen, V. ; Hu, S. ; Elamin, Y. ; Le, X. ; Goldberg, M. ; Wu, C. ; Zhang, J. ; Barreto, D. ; Rinsurongkawong, W. ; Simon, G. ; Roth, J. ; Swisher, S. ; Lee, J. ; Tsao, A. ; Papadimitrakopoulou, V. ; Gibbons, D. ; Glisson, B. ; Miller, V. ; Alexander, B. ; Frampton, G. ; Albacker, L. ; Shames, D. ; Heymach, J.
Source
In Journal of Thoracic Oncology October 2019 14(10) Supplement:S257-S258
Subject
Language
ISSN
1556-0864